| Literature DB >> 31878123 |
Gang Li1,2, Xiao Zhang1, Heying Qian1,2, Mingzhu Liu2, Guodong Zhao1,2, Anying Xu1,2.
Abstract
Fluoride tolerance is an important economic trait in sericulture, especially in some industrial development regions. Analyses of physiological changes involving structural damage to the insect body and molecular analyses of some related genes have focused on this area; however, the changes that occur at the metabolic level of silkworms after eating fluoride-contaminated mulberry leaves remain unclear. Here, metabonomic analysis was conducted using gas chromatography-mass spectrometry (GC-MS) to analyze the changes in midgut tissue after NaF stress using silkworm strains 733xin (susceptible stain) and T6 (strain resistant to fluoride), which were previously reported by our laboratory. Differential metabolomics analysis showed that both T6 and 733xin strains displayed complex responses after exposure to 200 mg/kg NaF. The purine metabolism and arginine and proline metabolic pathways of fluoride-tolerant strains reached significant levels, among which 3'-adenylic acid and hypoxanthine were significantly upregulated, whereas guanine, allantoic acid, xanthine, N-acetyl-L-glutamic acid, and pyruvate were significantly downregulated. These metabolic pathways may be related to the fluoride tolerance mechanism of NaF poisoning and tolerant strains.Entities:
Keywords: differential metabolites; fluoride tolerance; metabolic pathways; silkworm midgut; untargeted metabolomics
Year: 2019 PMID: 31878123 PMCID: PMC7023488 DOI: 10.3390/insects11010017
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Figure 1PCA score plots based on the GS-MS data of the Bombyx mori midgut samples.
Figure 2OPLS-DA model diagram. (A) OPLS-DA model diagram of T6_F-T6_C; (B) OPLS-DA model diagram of 733xin_F-733xin_C; (C) OPLS-DA model diagram of T6_C-733xin_C; (D) OPLS-DA model diagram of T6_F-733xin_F.Model parameter R2Y (the parameter value of this model does not refer to R2X value) represents the ability to interpret the model, and Q2 represents the ability to predict the model.
Common differential metabolites in four control groups.
| Metabolite | 733xin-F vs. 733xin-C | T6-F vs. T6-C | T6-C vs. 733xin-C | T6-F vs. 733xin-F | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIP |
| FC | VIP |
| FC | VIP |
| FC | VIP |
| FC | |
| raffinose | 1.9730 | <0.0001 | 2.6702 | 1.1615 | 0.0270 | 0.7653 | 1.2283 | 0.0008 | 1.9180 | 1.6267 | <0.0001 | 0.5497 |
| tricetin | 1.9949 | <0.0001 | 0.4461 | 1.1013 | 0.0379 | 1.3371 | 1.2692 | 0.0008 | 0.6576 | 1.4342 | 0.0009 | 1.9712 |
| arachidic acid | 1.8459 | 0.0001 | 0.6691 | 1.3336 | 0.0054 | 1.1608 | 1.6063 | <0.0001 | 0.4817 | 1.1006 | 0.0224 | 0.8358 |
| androstanediol | 1.7021 | 0.0001 | 0.6277 | 1.3489 | 0.0016 | 1.3559 | 1.2781 | <0.0001 | 0.6977 | 1.2835 | 0.0010 | 1.5070 |
| prostaglandin E2 | 1.7541 | 0.0005 | 1.2606 | 1.1868 | 0.0145 | 0.7736 | 1.0471 | 0.0082 | 1.3228 | 1.3324 | 0.0018 | 0.8118 |
| N-methyl-DL-alanine | 1.6075 | 0.0008 | 1.5624 | 1.3262 | 0.0092 | 1.1077 | 1.2269 | 0.0002 | 1.6073 | 1.1278 | 0.0161 | 1.1396 |
| nicotinamide | 1.2384 | 0.0028 | 0.5651 | 1.0728 | 0.0489 | 1.0777 | 1.1909 | 0.0043 | 1.2455 | 1.3247 | <0.0001 | 2.3752 |
| indole-3-acetamide | 1.7442 | 0.0075 | 2.5556 | 1.7658 | 0.0001 | 0.5501 | 1.4274 | 0.0001 | 1.9831 | 1.3437 | 0.0099 | 0.4269 |
| xylose | 1.4202 | 0.0144 | 0.3171 | 1.5321 | 0.0013 | 0.4759 | 1.5303 | <0.0001 | 8.0269 | 1.7642 | <0.0001 | 12.0456 |
| phosphate | 1.3474 | 0.0149 | 2.0608 | 1.4143 | 0.0063 | 1.4409 | 1.3344 | 0.0002 | 2.1808 | 1.0803 | 0.0229 | 1.5248 |
| D-alanyl-D-alanine | 1.3563 | 0.0160 | 1.1455 | 1.3713 | 0.0093 | 1.0976 | 1.2162 | 0.0014 | 1.1518 | 1.0003 | 0.0402 | 1.1036 |
| N-methyl-L-glutamic acid | 1.4813 | 0.0164 | 2.0773 | 1.8072 | <0.0001 | 0.4503 | 1.3420 | 0.0007 | 1.7325 | 1.3931 | 0.0048 | 0.3756 |
| glucosaminic acid | 1.3853 | 0.0191 | 1.3027 | 1.6018 | 0.0004 | 0.7394 | 1.2018 | 0.0025 | 1.3776 | 1.1969 | 0.0084 | 0.7820 |
| guanine | 1.4256 | 0.0207 | 1.5516 | 1.6091 | 0.0010 | 0.6318 | 1.1917 | 0.0091 | 1.6934 | 1.4074 | 0.0014 | 0.6895 |
| 5-methoxyindole-3-acetic acid | 1.3218 | 0.0268 | 1.4926 | 1.0875 | 0.0289 | 1.4566 | 1.2071 | 0.0010 | 0.5024 | 1.4787 | 0.0011 | 0.4903 |
| stigmasterol | 1.2893 | 0.0412 | 0.6565 | 1.2993 | 0.0055 | 1.5196 | 1.2808 | 0.0015 | 1.9553 | 1.7558 | <0.0001 | 4.5257 |
| melatonin | 1.1751 | 0.0416 | 1.1508 | 1.3098 | 0.0166 | 1.3538 | 1.2652 | 0.0010 | 1.2440 | 1.3180 | 0.0061 | 1.4634 |
| methyl-beta-D-galactopyranoside | 1.1474 | 0.0426 | 1.7359 | 1.7925 | <0.0001 | 0.5967 | 1.0187 | <0.0001 | 8.9987 | 1.8350 | <0.0001 | 3.0935 |
| alpha-D-glucosamine 1-phosphate | 1.2684 | 0.0449 | 1.5270 | 1.8635 | <0.0001 | 0.3464 | 1.2883 | 0.0012 | 1.7887 | 1.5467 | 0.0013 | 0.4058 |
| 5-hydroxyindole-2-carboxylic acid | 1.8575 | 0.0041 | 0.3829 | 1.4027 | 0.0182 | 0.5151 | 1.3143 | 0.0051 | 0.3682 | 1.8083 | <0.0001 | 0.4954 |
| nicotinic acid | 1.4744 | 0.0064 | 1.3137 | 1.7465 | <0.0001 | 0.6829 | 1.1216 | 0.0043 | 0.7923 | 1.8168 | <0.0001 | 0.4119 |
| cytidine-monophosphate | 1.8111 | 0.0068 | 0.4009 | 1.3625 | 0.0285 | 0.4958 | 1.2371 | 0.0124 | 0.4089 | 1.8005 | <0.0001 | 0.5057 |
The differential metabolites were selected on the basis of the combination of a statistically significant threshold of variable influence on projection (VIP) values obtained from the OPLS-DA model and p-values from a two-tailed Student’s t-test on the normalized peak areas, where metabolites with VIP values larger than 1 and p-values less than 0.05 were included, respectively.
Figure 3Categories of pathways in which the identified metabolites are involved. (A) metabolic pathway enrichment map of T6_F-T6_C; (B) metabolic pathway enrichment map of 733xin_F-733xin_C; (C) metabolic pathway enrichment map of T6_C-733xin_C; (D) metabolic pathway enrichment map of T6_F-733xin_F.
Partial identified differential metabolites of T6_F vs. T6_C and 733xin_F vs. 733xin_C.
| Metabolic Pathway | Metabolite | 733xin-F vs. 733xin-C | T6-F vs. T6-C | ||||
|---|---|---|---|---|---|---|---|
| VIP |
| FC | VIP |
| FC | ||
| Purine metabolism | 3′-adenylic acid | 1.4021 | 0.0146 | 1.5897 | 1.1089 | 0.0260 | 1.2742 |
| guanine | 1.4256 | 0.0207 | 1.5516 | 1.6091 | 0.0010 | 0.6318 | |
| xanthosine | 1.0500 | 0.0224 | 0.6018 | 1.1667 | 0.0279 | 0.8304 | |
| guanosine | 1.5426 | 0.0010 | 0.6137 | ||||
| allantoic acid | 1.4377 | 0.0034 | 0.6627 | ||||
| adenosine | 1.4556 | 0.0038 | 0.7421 | ||||
| hypoxanthine | 1.4200 | 0.0048 | 1.1328 | ||||
| Arginine and proline metabolism | N-acetyl-L-glutamic acid | 1.6081 | 0.0167 | 1.8397 | 1.8881 | <0.0001 | 0.3537 |
| glutamic acid | 1.8040 | <0.0001 | 0.7483 | ||||
| putrescine | 1.5495 | 0.0007 | 0.8533 | ||||
| pyruvic acid | 1.3513 | 0.0167 | 0.5493 | ||||
| fumaric acid | 2.0018 | <0.0001 | 1.2941 | 1.018 | 0.0414 | 0.9117 | |
| Urea | 1.7167 | 0.0004 | 1.7151 | ||||
| Alanine, aspartate and glutamate metabolism | L-glutamic acid | 1.8040 | <0.0001 | 0.7483 | |||
| succinic acid | 1.4135 | 0.0076 | 0.6709 | ||||
| pyruvic acid | 1.3513 | 0.0167 | 0.5493 | ||||
| fumaric acid | 2.0018 | <0.0001 | 1.2941 | 1.018 | 0.0414 | 0.9117 | |
| Nicotinate and nicotinamide metabolism | nicotinic acid | 1.4744 | 0.0064 | 1.3137 | 1.7465 | <0.0001 | 0.6829 |
| pyruvic acid | 1.3513 | 0.0167 | 0.5493 | ||||
| fumaric acid | 2.0018 | <0.0001 | 1.2941 | 1.018 | 0.0414 | 0.9117 | |
| nicotinamide | 1.2384 | 0.0028 | 0.5651 | 1.0728 | 0.0489 | 1.0777 | |
| Oxidative phosphorylation | phosphate | 1.3474 | 0.0149 | 2.0608 | 1.4143 | 0.0063 | 1.4409 |
| succinic acid | 1.4135 | 0.0076 | 0.6709 | ||||
| fumaric acid | 2.0018 | <0.0001 | 1.2941 | 1.018 | 0.0414 | 0.9117 | |
| pyrophosphate | 1.5484 | 0.0054 | 1.6668 | ||||
| Tryptophan metabolism | indoleacetonitrile | 1.7692 | <0.0001 | 0.4340 | |||
| indole-3-acetamide | 1.7442 | 0.0075 | 2.5556 | 1.7658 | 0.0001 | 0.5501 | |
| aminophenol | 1.2944 | 0.0150 | 0.0892 | 1.0252 | 0.0025 | 0.4543 | |
| 5-methoxytryptamine | 1.3455 | 0.0130 | 0.7748 | ||||
| hydroxyanthranilic acid | 1.3539 | 0.0141 | <0.0001 | ||||
| melatonin | 1.1751 | 0.0416 | 1.1508 | 1.3098 | 0.0166 | 1.3538 | |
| indolelactate | 1.7985 | 0.0013 | 0.7070 | ||||
| N-acetylisatin | 1.2651 | 0.0152 | 1.4572 | ||||
| Glutathione metabolism | L-glutamic acid | 1.8040 | <0.0001 | 0.7483 | |||
| putrescine | 1.5495 | 0.0007 | 0.8533 | ||||
| L-cysteine | 1.4476 | 0.0172 | 0.8256 | ||||
| glycine | 1.3452 | 0.0253 | 0.8108 | ||||
The differential metabolites were selected on the basis of the combination of a statistically significant threshold of variable influence on projection (VIP) values obtained from the OPLS-DA model and p-values from a two-tailed Student’s t-test on the normalized peak areas, where metabolites with VIP values larger than 1 and p values less than 0.05 were included, respectively.
Figure 4Differential metabolites between T6_F vs. T6_C are located in oxidative phosphorylation. Red dots indicate upregulated in oxidative phosphorylation and blue dots indicates downregulated in oxidative phosphorylation. The originated figure from KEGG pathway database.
Figure 5Differential metabolites between T6_F vs. T6_C are located in Arginine, Proline, Alanine, Aspartate, and Glutamate metabolism. Blue color metalites indicates downregulated.
Figure 6Differential metabolites between T6_F vs. T6_C are located in Purine metabolism. Red indicates upregulated in purine metabolism and blue indicates downregulated in purine metabolism.